CETP and coronary artery disorder: The B2 allele, absence of the TaqI restriction site, has been found to be associated with elevated plasma HDL-C level and reduced plasma CETP mass and activity and coronary heart disease (CHD) risk [9-12], and accordingly to be associated with longer life expectancy [13,14].